The study concluded that treatment with ultrasound-facilitated catheter-directed low-dose thrombolysis for acute pulmonary embolism improves right heart function, reduces blood clot size, and decreases pulmonary hypertension in patients with intermediate to high risk pulmonary embolism.
Updating national screening policies could help detect a deadly form of aneurysm in older men; saving lives and resources, according to research presented in the Journal of the American Heart Association.
Ian Franklin, a member of the CX Programme Organising Board and director of the CX Venous Workshop, speaks about new technologies for the treatment of varicose veins and about how deep venous interventions have been incorporated to the hands-on workshop.
In this interview, Janet Powell explains why the cause and management of abdominal aortic aneurysms are her major research interests and speaks about her early career, her mentors, the IMPROVE randomised controlled trial, and also her interests outside medicine.
Jean-Baptiste Ricco, Poitiers, France, is the immediate past-president of ESVS and for over 15 years held an editor’s position with EJVES. In this interview, Ricco tells Vascular News about his mentors in vascular surgery, achievements in the ESVS and journal, and his volunteering experience ...
Gunnar Tepe was involved in the development of the first drug-coated balloons for the treatment of peripheral arterial disease. Tepe, who is also principal investigator of the IN.PACT SFA trial, tells Vascular News about his career, drug-eluting balloons research and interests outside medicine ...
The Ranger drug-coated balloon (Boston Scientific) is indicated for percutaneous transluminal angioplasty in the peripheral vasculature. It has been designed to provide consistent and predictable drug delivery through efficient drug transfer, and a strong coating integrity.